跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 548 条关于
“ropeginterferon”
全部
548
临床试验
474
药物
45
机构
0
资讯
29
3年前
Ropeginterferon Alfa-2b: Optimized Dosing Strategies Show Promise in Myeloproliferative Neoplasms
11年前
Ropeginterferon Alfa-2b Shows Promise in Polycythemia Vera Treatment
3年前
Ropeginterferon Alfa-2b Shows Promise in Hydroxyurea-Resistant Essential Thrombocythemia
11年前
Ropeginterferon Alfa-2b Evaluated as Second-Line Therapy for High-Risk Essential Thrombocythemia in SURPASS-ET Trial
去年
NFKB1 Haplotype Predicts Improved Response to Ropeginterferon Alfa-2b in PV and ET
去年
PharmaEssentia's Ropeginterferon Shows Promising Results in Phase 3 Trial for Essential Thrombocythemia
3年前
Ropeginterferon Alfa-2b Shows Promise as Second-Line Treatment for High-Risk Essential Thrombocythemia
去年
Ropeginterferon Alfa-2b Shows Superior Efficacy Over Anagrelide in Phase III Essential Thrombocythemia Trial
9个月前
Ropeginterferon Alfa-2b Shows Superior Efficacy Over Anagrelide in Phase 3 Essential Thrombocythemia Trial
9个月前
AOP Health Presents New Clinical Data for Ropeginterferon Alfa-2b in Rare Blood Cancers at ASH 2025
第 1 页,共 3 页
上一页
下一页